The goal of the current study was to assess the potential role of anxiety and depression on pain catastrophizing in older adults with chronic pain.
Bafiertam, a novel fumarate bioequivalent alternative to its prodrug dimethyl fumarate, is now available for multiple sclerosis.
Use of medical marijuana is associated with fewer hospitalizations among patients with sickle cell disease.
Changes in connectivity between the dorsal anterior cingulate cortex and regions of the brain involved in pain processing and motor control may predict the development of chronic pain months after a motor vehicle crash.
The use of regular, low-dose, oral sustained-release morphine for 4 weeks in patients with COPD and moderate to very severe breathlessness has been shown to improve disease-specific health status.
The TEACH intervention increases adherence to guideline-concordant care for HIV patients with chronic pain.
Behavioral management of chronic pain may improve addiction treatment outcomes.
Anxiety sensitivity may mediate the indirect effect of anxiety and depressive symptoms on opioid misuse in those with chronic pain.
Those eligible for corticosteroid injections during the COVID-19 pandemic with relatively well-controlled pain should be counseled regarding procedure deferral until the pandemic subsides.
Investigators aimed to determine whether vaporized cannabis would reduce symptoms of chronic pain in adult patients with sickle cell disease.